Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Contreras

Showing results (111-120 of 122) with videos related to

Pageof 13
Sort By:
ACS Chemical Biology|April 3, 2018
Chemical Genetic Screens Identify Kinase Inhibitor Combinations that Target Anti-Apoptotic Proteins for Cancer TherapyJacob I Contreras, Caroline M Robb, Hannah M King, et al.
European Journal of Medicinal Chemistry|June 7, 2021
Structure activity relationship (SAR) study identifies a quinoxaline urea analog that modulates IKKβ phosphorylation for pancreatic cancer therapySatish Sagar, Sarbjit Singh, Jayapal Reddy Mallareddy, et al.
Molecular Pharmacology|August 31, 2019
CDK5 Inhibitor Downregulates Mcl-1 and Sensitizes Pancreatic Cancer Cell Lines to NavitoclaxSmit Kour, Sandeep Rana, Jacob I Contreras, et al.
Cancer Research|September 18, 2002
The hepatocyte nuclear factor 3 alpha gene, HNF3alpha (FOXA1), on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomasLin Lin, Charles T Miller, Jorge I Contreras, et al.
Actas Dermo-Sifiliograficas|June 20, 2017
Platelet-Rich Plasma for the Treatment of Photodamage of the Skin of the HandsJ O Cabrera-Ramírez, A G Puebla-Mora, A González-Ojeda, et al.
Oncotarget|February 14, 2018
Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapyCaroline M Robb, Smit Kour, Jacob I Contreras, et al.
Oncotarget|July 9, 2020
Correction: Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapyCaroline M Robb, Smit Kour, Jacob I Contreras, et al.
Journal of Medicinal Chemistry|June 8, 2017
Development of 1-((1,4-trans)-4-Aryloxycyclohexyl)-3-arylurea Activators of Heme-Regulated Inhibitor as Selective Activators of the Eukaryotic Initiation Factor 2 Alpha (eIF2α) Phosphorylation Arm of the Integrated Endoplasmic Reticulum Stress ResponseRevital Yefidoff-Freedman, Jing Fan, Lu Yan, et al.
Emerging Infectious Diseases|December 25, 2009
Severe pneumonia associated with pandemic (H1N1) 2009 outbreak, San Luis Potosí, MexicoAlejandro Gómez-Gómez, Martin Magaña-Aquino, Christian Garcia-Sepúlveda, et al.
European Journal of Cancer Care|May 6, 2017
Effects of preoperative dexamethasone on postoperative pain, nausea, vomiting and respiratory function in women undergoing conservative breast surgery for cancer: Results of a controlled clinical trialA O Cortés-Flores, J Jiménez-Tornero, G Morgan-Villela, et al.
Pageof 13

Showing results (111-120 of 122) with videos related to

Sort By:
Pageof 13
ACS Chemical Biology|April 3, 2018
Chemical Genetic Screens Identify Kinase Inhibitor Combinations that Target Anti-Apoptotic Proteins for Cancer TherapyJacob I Contreras, Caroline M Robb, Hannah M King, et al.
European Journal of Medicinal Chemistry|June 7, 2021
Structure activity relationship (SAR) study identifies a quinoxaline urea analog that modulates IKKβ phosphorylation for pancreatic cancer therapySatish Sagar, Sarbjit Singh, Jayapal Reddy Mallareddy, et al.
Molecular Pharmacology|August 31, 2019
CDK5 Inhibitor Downregulates Mcl-1 and Sensitizes Pancreatic Cancer Cell Lines to NavitoclaxSmit Kour, Sandeep Rana, Jacob I Contreras, et al.
Cancer Research|September 18, 2002
The hepatocyte nuclear factor 3 alpha gene, HNF3alpha (FOXA1), on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomasLin Lin, Charles T Miller, Jorge I Contreras, et al.
Actas Dermo-Sifiliograficas|June 20, 2017
Platelet-Rich Plasma for the Treatment of Photodamage of the Skin of the HandsJ O Cabrera-Ramírez, A G Puebla-Mora, A González-Ojeda, et al.
Oncotarget|February 14, 2018
Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapyCaroline M Robb, Smit Kour, Jacob I Contreras, et al.
Oncotarget|July 9, 2020
Correction: Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapyCaroline M Robb, Smit Kour, Jacob I Contreras, et al.
Journal of Medicinal Chemistry|June 8, 2017
Development of 1-((1,4-trans)-4-Aryloxycyclohexyl)-3-arylurea Activators of Heme-Regulated Inhibitor as Selective Activators of the Eukaryotic Initiation Factor 2 Alpha (eIF2α) Phosphorylation Arm of the Integrated Endoplasmic Reticulum Stress ResponseRevital Yefidoff-Freedman, Jing Fan, Lu Yan, et al.
Emerging Infectious Diseases|December 25, 2009
Severe pneumonia associated with pandemic (H1N1) 2009 outbreak, San Luis Potosí, MexicoAlejandro Gómez-Gómez, Martin Magaña-Aquino, Christian Garcia-Sepúlveda, et al.
European Journal of Cancer Care|May 6, 2017
Effects of preoperative dexamethasone on postoperative pain, nausea, vomiting and respiratory function in women undergoing conservative breast surgery for cancer: Results of a controlled clinical trialA O Cortés-Flores, J Jiménez-Tornero, G Morgan-Villela, et al.
Pageof 13